Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 26, Issue 1, 2015, Pages 13-23

  Prakash, Atish ^a   Kalra, Jaspreet Kaur ^a   Kumar, Anil ^b  

^a ISF COLLEGE OF PHARMACY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

memory dysfunction; mitochondria; N acetyl cysteine; oxidative stress; streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLCYSTEINE; CASPASE 3; INTERLEUKIN 6; MITOCHONDRIAL ENZYME; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOPLASM; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; COGNITION DISORDERS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MEMORY DISORDERS; MITOCHONDRION; PATHOLOGY; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MEMORY DISORDERS; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84920847986     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2013-0150     Document Type: Article

References (47)

1. Massaad CA. Neuronal and vascular oxidative stress in Alzheimer's disease. Curr Neuropharmacol 2011;9:662-73.
2. Shi Q, Fu J, Ge D, He Y, Ran J, Liu Z, et al. Huperzine A ameliorates cognitive deficits and oxidative stress in the hippocampus of rats exposed to acute hypobaric hypoxia. Neurochem Res 2012;37:2042-52.
3. Tillement L, Lecanu L, Papadopoulos V. Alzheimer's disease: effects of beta-amyloid on mitochondria. Mitochondrion 2011;11:13-21.
4. Prakash AK, Kumar A. Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats. J Pharma Pharmacol 2009;61:1665-72.
5. Landsberg GM, Nichol J, Araujo JA. Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract 2012;42:749-68.
6. Calingasan NY, Ho DJ, Wille EJ, Campagna MV, Ruan J, Dumont M, et al. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neurosci 2008;153:986-96.
7. Gobbo MG, Ribeiro DL, Taboga SR, de Almeida EA, Goes RM. Oxidative stress markers and apoptosis in the prostate of diabetic rats and the influence of vitamin C treatment. J Cell Biochem 2012;113:2223-33.
8. Tota S, Awasthi H, Kamat PK, Nath C, Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 2010;209:73-9.
9. Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacol 2007;52:836-43.
10. Lu H, Zhang DM, Chen HL, Lin YX, Hang CH, Yin HX, et al. N-Acetylcysteine suppresses oxidative stress in experimental rats with subarachnoid hemorrhage. J Clin Neurosci 2009;16:684-8.
11. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003;84:1173-83.
12. Grosicka-Maciag E, Kurpios-Piec D, Szumilo M, Grzela T, Rahden-Staron I. Protective effect of N-acetyl-L-cysteine against maneb induced oxidative and apoptotic injury in Chinese hamster V79 cells. Food Chem Toxicol 2011;49:1020-5.
13. Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966;99:667-76.
14. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [N-15]-labeled nitrate in biological-fluids. Anal Biochem 1982;126:131-8.
15. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide-dismutase. Arch Biochem Biophys 1978;186:189-95.
16. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
17. Zahler WL, Cleland WW. A specific and sensitive assay for disulfides. J Biol Chem 1968;243:716-9.
18. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-9.
19. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-90.
20. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751-66.
21. Berman SB, Hastings TG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 1999;73:1127-37.
22. King TE, Howard RL. Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. In: Ronald W. Estabrook MEP, editors. Methods in enzymology. PA, USA: Elsevier, Academic Press, 1967:275-94.
23. King TE. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Ronald W. Estabrook MEP, editors. Methods in enzymology. PA, USA: Elsevier, Academic Press,, 1967:322-31.
24. Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 1997;69:581-93.
25. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 1967;32:415-38.
26. Millea PJ. N-Acetylcysteine: multiple clinical applications. Am Fam Physician 2009;80:265-9.
27. Arakawa M, Ito Y. N-Acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 2007;6:308-14.
28. Sherin A, Anu J, Peeyush KT, Smijin S, Anitha M, Roshni BT, et al. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocininduced diabetic rats. Neuroscience 2012;202:69-76.
29. Lee SH, Kim KR, Ryu SY, Son S, Hong HS, Mook-Jung I, et al. Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J Neurosci 2012;32:5953-63.
30. Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2011;221:555-63.
31. Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother 2008;8:1703-18.
32. Orszaghova Z, Ulicna O, Liptakova A, Zitnanova I, Muchova J, Watala C, et al. Effects of N1-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocininduced diabetes mellitus. Redox Rep 2012;17:1-7.
33. Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 2012;120:419-29.
34. Moran M, Moreno-Lastres D, Marin-Buera L, Arenas J, Martin MA, Ugalde C. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration. Free Radical Biol Med 2012;53: 595-609.
35. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012;322:254-62.
36. Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol 2009;41:1989-2004.
37. Tucci P, Cione E, Perri M, Genchi G. All-trans-retinoic acid induces apoptosis in Leydig cells via activation of the mitochondrial death pathway and antioxidant enzyme regulation. J Bioenerg Biomembr 2008;40:315-23.
38. Snigdha S, Smith ED, Prieto GA, Cotman CW. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci Bull 2012;28:14-24.
39. Vassar R. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease. Neuron 2007;54:671-3.
40. Lee JE, Park JH, Shin IC, Koh HC. Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to chlorpyrifos. Toxicol Appl Pharmacol 2012;263:148-62.
41. Kamat PK, Tota S, Shukla R, Ali S, Najmi AK, Nath C. Mitochondrial dysfunction: A crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav 2011;100:311-19.
42. Ye L, Wang F, Yang RH. Diabetes impairs learning performance and affects the mitochondrial function of hippocampal pyramidal neurons. Brain Res 2011;1411:57-64.
43. Negi G, Kumar A, Sharma SS. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J Pineal Res 2011;50:124-31.
44. Prakash A, Kumar A. Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin Pharmacol Toxicol 2009;105:98-104.
45. Choy KH, Dean O, Berk M, Bush AI, van den Buuse M. Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-onetreated rats. Eur J Pharmacol 2010;649:224-8.
46. Aktunc E, Ozacmak VH, Ozacmak HS, Barut F, Buyukates M, Kandemir O, et al. NAC promotes angiogenesis and clearance of free oxygen radicals, thus improving wound healing in an alloxan-induced diabetic mouse model of incisional wound. Clin Exp Dermatol 2010;35:902-9.
47. Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, et al. Lipoic acid and NAC decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimer's Dis 2007;12:195-206.